Brugada syndrome is a genetic heart condition that disrupts the electrical signals controlling your heartbeat, raising the risk of dangerous irregular rhythms and sudden cardiac arrest. It affects roughly 1 in 2,000 people worldwide, often shows no warning signs, and is typically diagnosed through an electrocardiogram (ECG). The heart itself looks structurally normal, which is part of what makes the condition so difficult to catch.
What Happens in the Heart
Your heart relies on tiny channels in its cells that let charged particles (mainly sodium) flow in and out to generate each heartbeat. In Brugada syndrome, these sodium channels don’t work properly. The most commonly identified genetic cause involves mutations in a gene called SCN5A, which provides the blueprint for these channels. When fewer sodium ions enter heart cells at the right time, the electrical signal can become uneven across different layers of the heart wall, particularly in the right ventricle.
That uneven signaling creates a window where a chaotic rhythm called ventricular fibrillation can start. During ventricular fibrillation, the heart quivers instead of pumping blood. Without immediate intervention, it’s fatal within minutes. The electrical abnormality is concentrated on the outer surface (epicardium) of the right ventricle, which is why the condition produces its characteristic pattern on an ECG in the leads placed over the right side of the chest.
Symptoms and Warning Signs
Many people with Brugada syndrome never experience symptoms. The condition is often discovered incidentally during a routine ECG or after a family member has a sudden cardiac event. When symptoms do appear, they tend to include unexplained fainting (syncope), seizure-like episodes, or gasping, labored breathing during sleep known as nocturnal agonal respiration. These episodes typically happen at rest or during sleep, when the nervous system shifts toward a state that slows the heart rate and can worsen the underlying electrical instability.
In the most severe cases, the first sign of Brugada syndrome is sudden cardiac arrest. This is why the condition is considered one of the leading causes of sudden cardiac death in young, otherwise healthy adults, particularly in Southeast Asia, where it has historically been recognized as a cause of unexplained death during sleep.
Who Is Most at Risk
Brugada syndrome is significantly more common in certain populations and demographics. A large meta-analysis found the highest prevalence in Southeast Asia at 3.7 per 1,000 people. Thailand alone had a pooled prevalence of 6.8 per 1,000, roughly 14 times higher than the global average. In comparison, the prevalence in Europe is about 0.1 per 1,000 and in North America just 0.05 per 1,000. People of Asian ethnicity are nine times more likely to have the condition than Caucasians and 36 times more likely than Hispanics.
Men are affected far more often than women, with a prevalence of 0.6 per 1,000 compared to 0.1 per 1,000 in women. Testosterone is believed to play a role in this disparity, which is why symptoms most commonly appear in adulthood, typically between the ages of 30 and 50. The condition runs in families and follows an autosomal dominant inheritance pattern, meaning a child of someone with the mutation has a 50% chance of inheriting it.
How Brugada Syndrome Is Diagnosed
Diagnosis centers on the ECG. Doctors look for a specific abnormal pattern in the leads placed over the right side of the chest (V1 through V3). There are three recognized patterns, but only one is considered diagnostic on its own.
- Type 1 (coved pattern): A dome-shaped rise in the ST segment of at least 2 mm, followed by an inverted T wave. This is the only pattern that confirms the diagnosis.
- Type 2 (saddleback pattern): A saddle-shaped ST elevation of at least 2 mm with a positive or two-phase T wave. Suggestive but not diagnostic by itself.
- Type 3: A smaller ST elevation of less than 1 mm. Considered nonspecific and not independently useful for diagnosis.
The tricky part is that the diagnostic Type 1 pattern can come and go. Some people only show it during a fever, after certain medications, or at specific times of day. A normal ECG does not rule out the condition.
Provocation Testing
When a doctor suspects Brugada syndrome but the ECG doesn’t show the Type 1 pattern, a provocation test can be used. This involves giving a medication that temporarily blocks sodium channels to see if the characteristic pattern emerges. The test is done under continuous monitoring in a hospital setting. If the Type 1 pattern appears in at least two right-sided leads, the test is considered positive. These tests have a strong safety profile, with serious rhythm disturbances during the procedure being rare.
Risk also depends on whether the Type 1 pattern appears on its own or only after provocation. One large study of over 1,100 people with the condition who had no symptoms found that those with a spontaneous Type 1 pattern had a 14-fold higher risk of a dangerous heart rhythm event compared to those whose pattern only showed up during a drug challenge (3% vs. 0.16% over six years of follow-up).
Triggers to Avoid
Fever is one of the most important triggers for people with Brugada syndrome. Elevated body temperature can worsen sodium channel dysfunction and unmask or intensify the dangerous ECG pattern. If you have Brugada syndrome, treating any fever promptly with standard over-the-counter fever reducers is a key part of ongoing management.
Certain medications pose a serious risk because they further impair sodium channel function. Categories to be aware of include:
- Certain heart rhythm drugs: Particularly those in the sodium channel blocker class.
- Some antidepressants: Several tricyclic antidepressants, including amitriptyline, nortriptyline, and clomipramine, are on the avoidance list.
- Lithium: Commonly used for bipolar disorder.
- Some anesthetics: Certain local and general anesthetics can be problematic, which is important to communicate before any surgical procedure.
- Cocaine and excessive alcohol: Both can provoke arrhythmias in people with the condition.
A comprehensive and regularly updated list of drugs categorized by risk level is maintained at brugadadrugs.org. If you’ve been diagnosed, keeping this list accessible and sharing it with any new healthcare provider, dentist, or anesthesiologist is essential.
Treatment Options
The primary treatment for people at high risk of sudden cardiac arrest is an implantable cardioverter-defibrillator, or ICD. This small device, placed under the skin near the collarbone, continuously monitors heart rhythm. If it detects ventricular fibrillation, it delivers an electric shock to restore a normal rhythm within seconds. ICDs are generally recommended for anyone who has survived a cardiac arrest, experienced dangerous arrhythmias, or has a spontaneous Type 1 pattern along with fainting episodes.
For people who have the ECG pattern but no symptoms and no family history of sudden death, management is more conservative. It typically centers on avoiding known triggers, treating fevers aggressively, and regular follow-up with a cardiologist.
Catheter Ablation
A newer treatment option targets the root of the electrical problem directly. Epicardial catheter ablation involves threading a catheter to the outer surface of the right ventricle and using heat energy to eliminate the areas of abnormal tissue responsible for the faulty electrical signals. A recent randomized clinical trial found striking results: after an average follow-up of four years, 96% of patients who underwent ablation remained free of ventricular fibrillation, compared to just 50% of those treated with an ICD alone. After ablation, the characteristic Brugada ECG pattern disappeared and could no longer be provoked with sodium channel blockers.
At this stage, ablation is used alongside ICDs rather than replacing them, primarily in high-risk patients who have already experienced cardiac arrest or received ICD shocks for dangerous rhythms. But the results suggest it can fundamentally alter how the disease expresses itself by removing the abnormal tissue that drives it.
Living With Brugada Syndrome
For most people diagnosed with Brugada syndrome, daily life doesn’t require dramatic changes. The practical priorities are knowing your triggers, carrying your medication list, and making sure the people around you know what to do if you faint or collapse. If you have an ICD, you’ll need periodic device checks, typically every six to twelve months, and you’ll want to avoid strong magnetic fields and certain types of contact sports that could damage the device.
Because the condition is inherited, genetic testing and ECG screening for close family members is an important step after any diagnosis. Siblings and children of someone with Brugada syndrome each have a meaningful chance of carrying the same mutation, even if they’ve never had symptoms. Identifying them early allows for monitoring and trigger avoidance before a first event ever occurs.